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Ensemble machine learning 
prediction and variable importance 
analysis of 5‑year mortality 
after cardiac valve and CABG 
operations
José Castela Forte 1,2,7*, Hubert E. Mungroop2, Fred de Geus2, Maureen L. van der Grinten7, 
Hjalmar R. Bouma1,3, Ville Pettilä4, Thomas W. L. Scheeren 2, Maarten W. N. Nijsten5, 
Massimo A. Mariani6, Iwan C. C. van der Horst 5,8, Robert H. Henning1, Marco A. Wiering7 & 
Anne H. Epema2
Despite having a similar post‑operative complication profile, cardiac valve operations are associated 
with a higher mortality rate compared to coronary artery bypass grafting (CABG) operations. For 
long‑term mortality, few predictors are known. In this study, we applied an ensemble machine 
learning (ML) algorithm to 88 routinely collected peri‑operative variables to predict 5‑year 
mortality after different types of cardiac operations. The Super Learner algorithm was trained using 
prospectively collected peri‑operative data from 8241 patients who underwent cardiac valve, CABG 
and combined operations. Model performance and calibration were determined for all models, and 
variable importance analysis was conducted for all peri‑operative parameters. Results showed that 
the predictive accuracy was the highest for solitary mitral (0.846 [95% CI 0.812–0.880]) and solitary 
aortic (0.838 [0.813–0.864]) valve operations, confirming that ensemble ML using routine data 
collected perioperatively can predict 5‑year mortality after cardiac operations with high accuracy. 
Additionally, post‑operative urea was identified as a novel and strong predictor of mortality for several 
types of operation, having a seemingly additive effect to better known risk factors such as age and 
postoperative creatinine.
Whereas complications after cardiac operations are associated with increased risk of in-hospital mortality, only 
few predict long-term mortality. The best documented is post-operative acute kidney injury (AKI), a highly 
prevalent complication occurring in 15–30% of  patients1,2 which is associated with both increased short- and 
long-term  mortality1–4. The relation between postoperative AKI and mortality varies greatly per type of cardiac 
operation. Mortality risks related to AKI are well characterized for coronary artery bypass grafting (CABG), but 
less well studied in valve operations, despite these accounting for 24% of all cardiac operations and having higher 
mortality  rates5,6. Recently, Bouma et al.5, showed post-operative AKI to be strongly associated with an increase in 
long-term mortality in patients with solitary valve and combined valve and CABG operations. Remarkably, even 
a mild impairment in renal function well below the threshold for AKI-1 (i.e., a mere 10% post-operative increase 
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in serum creatinine) significantly increased long-term mortality risk in solitary valve  operations5. Therefore, 
to date postoperative AKI represents the best studied organ injury related early marker of long-term mortality 
risk after cardiac operations.
Previously, we have demonstrated that machine learning (ML) predictive models proved superior to classical 
multivariable analysis in identifying patients at increased risk of long-term mortality after CABG  operations7. 
Moreover, a unique property of ML is its ability to identify parameters predicting mortality and rank their 
importance by variable importance analysis. However, while ML analyses gain popularity in peri-operative 
 care8, studies using ML techniques for long-term mortality analysis after cardiac valve operations are lacking. 
Several studies in different fields of healthcare have shown ensemble ML algorithms to be more accurate than 
individual algorithms in modelling complex outcomes such as mortality in critically ill  patients9 and mortality 
following cardiac  arrest10. In anesthesiology, recent studies showed that different machine learning algorithms 
could accurately predict acute hypotensive episodes 10 min in advance using patient characteristics and physi-
ological  variables11–13.
In this study, we combined multiple ML algorithms into an ensemble using the Super Learner (SL)  algorithm14. 
This ensemble ML algorithm was trained to predict 5-year mortality in a large prospective cohort of patients 
undergoing cardiac valve, CABG, or combined operations using routinely collected peri-operative data in a single 
tertiary care hospital. We compared the accuracy of two SL training methodologies, using a targeted approach 
with patients split per operation type compared to the entire, unselected population. Furthermore, variable 
importance analysis was conducted to identify the strongest predictors of mortality.
Results
Patient characteristics and mortality per operation type. Patient characteristics, descriptives of all 
variables used in this study and mortality data per operation type are summarized in Table 1 (and Table 1 of the 
“Supplementary material”). Five years mortality rate of the full patient cohort was 16.5%. Operations involving 
valve procedures showed higher mortality amounting 16.9% for aortic valve alone, 19.7% for mitral valve alone, 
21.0% for combined aortic valve/CABG and 28.9% for combined mitral valve/CABG (Table 1). Accordingly, 
mortality rate for CABG-only (13.8%) was lower than for the entire cohort.
Machine learning analysis. As a first step in the ML based prediction of long-term mortality, the ensemble 
was trained on the full cohort (SL1; Fig. 5, left part). ROC curves and their respective AUROCs were established 
for the full cohort and the different cardiac operation types (Fig. 1). SL1 achieved an AUROC of 0.810 [0.798–
0.823]. When analyzed per operation type, the accuracy of SL1 was highest for solitary mitral valve (0.846) and 
solitary aortic valve operations (0.838), and lowest for solitary CABG (0.784) and mitral valve/CABG (0.796). 
In addition, the comparison between SL1 and the trained GLM showed that the SL1 significantly outperformed 
GLM (AUROC 0.756 [0.725–0.787]) for the full cohort (P = 0.0016; Fig. 1) as well as for solitary aortic valve and 
combined aortic valve and CABG (P < 0.01; Table 2 in the “Supplementary material”). Thus, SL1 produced sound 
long-term mortality prediction based on peri-operative routinely collected patient and operation data. 
Next, we performed a similar analysis based on SL training per operation type, by making five training sets 
using 80% of the relevant patients to train five weighted ensembles (SL2–SL6). Comparison of AUROCs between 
SL1 versus SL2–6, showed identical ranking for specific operation subgroups. Predictive performance between 
the models generated by SL1 compared those from SL2 to SL6 did not differ (Fig. 1; Table 2 in the “Supplemen-
tary material”). SL3 and SL4 also outperformed GLM (P < 0.01; Table 4 in the “Supplementary material”). Lastly, 
because of its potential ability to identify patients at high risk prior to surgery, we examined the predictive per-
formance when only pre-operative data are included. As expected, the model trained only on pre-operative data 
showed inferior performance to the full peri-operative model (AUROC 0.718 [0.687–0.749], P < 0.01, Fig. 12 in 
the “Supplementary material”).
Calibration, sensitivity analysis and adjusted risk thresholds based on predicted probability 
of mortality. Calibration of SL1 and SL2–6 was good for most models (Table 5 and Figs. 1–11 of the “Sup-
plementary material”). Using the adjusted thresholds based on the Youden index and on a 50% increased risk of 
mortality lead to improved model sensitivity and specificity (Fig. 2). For all operations, the thresholds based on 
the Youden index approximated the baseline absolute mortality risk. Compared to the default threshold of 50% 
mortality risk, both the thresholds based on the Youden index and the thresholds defined by a 50% increased 
risk of mortality increased sensitivity substantially for all types of operation (Tables 6–15 of the “Supplementary 
material”). For the Youden index thresholds, this was paired with a steeper decrease in specificity than for the 
thresholds at 50% increased risk of mortality. As Table 2 shows, the threshold representing 50% increase in risk 
improved the number of patients correctly classified as “non-survivor” for all types of operation. The largest 
increase in correctly classified “non-survivors” was observed for aortic valve, CABG, combined aortic valve and 
CABG, and for all operations combined (3-, 4.7-, 2.2-, and 3-fold increase).
Variable importance analysis. Unexpectedly, variable importance analysis of all operations combined 
(n = 8142) revealed serum urea at day 4 after operation as the top predictor variable for 5-year mortality (Fig. 3). 
Serum urea was also found the top predictor in all operation types, except for the smallest group (n = 367), com-
bined mitral valve and CABG operations. Other important predictive variables included patient age, serum urea 
at other time points, indicators of kidney function, and serum markers for organ damage and inflammation. To 
better illustrate the impact of the changes in these variable and possible interactions, we constructed probability 
plots of the two highest ranking variables in all patients (Fig. 4). Mortality risk steeply increased from day 4 
urea levels of 10 mmol/L, reaching a plateau at 30 mmol/L denoting a 50% increase in absolute risk compared 
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CABG Aortic valve Mitral valve Aortic + coronary Mitral + coronary
P valueN = 4514 N = 1663 N = 884 N = 813 N = 367
BMI 27.34 27.01 26.03 27.40 26.56 < 0.001
Gender < 0.001
Female 1028 (22.77%) 676 (40.65%) 424 (47.96%) 285 (35.06%) 125 (34.06%)
Male 3486 (77.23%) 987 (59.35%) 460 (52.04%) 528 (64.94%) 242 (65.94%)
Age 66.26 64.80 (13.79) 62.62 (13.62) 72.25 (8.39) 69.28 (8.57) < 0.001
Pre-operative eCCR 71.42 72.32 (21.84) 74.83 74.54 65.78 0.065
Post-operative eCCR 66.99 70.50 (39.87) 67.43 (27.26) 62.94 (24.22) 59.03 (23.90) < 0.001
Per-operative eCCR decrease 4.44 1.82 (32.85) 7.40 (95.76) 11.60 (106.61) 6.75 (16.49) 0.001
Pre-operative eCCR ratio 1.13 1.11 (0.38) 1.27 (2.26) 1.25 (1.18) 1.23 (0.50) 0.001
Creatinine within 24 h before 
surgery (μmol/L) 102.69 100.31 (78.26) 98.75 (44.46) 104.65 (79.01) 107.90 (72.40) 0.138
Pre-operative creatinine 101.95 99.21 (72.06) 98.15 (40.11) 102.89 (68.31) 107.11 (70.80) 0.110
Creatinine 12–24 h after 
surgery 91.83 89.10 (74.79) 89.15 (45.57) 96.46 (68.71) 102.09 (65.22) 0.002
Creatinine 24 h after surgery 92.84 90.71 (73.06) 91.85 (45.48) 98.40 (70.21) 103.72 (65.53) 0.002
Creatinine at day 2 after 
surgery 102.72 99.13 (73.60) 96.19 (49.84) 104.08 (66.63) 107.76 (56.25) 0.006
Creatinine at day 4 after 
surgery 98.61 94.35 (75.25) 93.75 (57.22) 100.73 (74.97) 104.61 (69.26) 0.007
Maximum post-operative 
creatinine 111.03 108.53 (86.88) 110.96 (64.41) 119.15 (86.85) 126.22 (76.60) < 0.001
Absolute difference in 
creatinine 9.08 9.32 12.81 (46.89) 16.26 (43.28) 19.11 (44.45) < 0.001
Relative difference in 
creatinine 1.10 1.09 1.19 1.19 (0.79) 1.19 (0.40) < 0.001
Percentual difference in 
creatinine 10.20 8.71 19.27 19.45 (79.05) 18.96 (39.91) < 0.001
Urea within 24 h before 
surgery (mmol/L) 6.96 7.25 8.09 7.57 (3.27) 8.20 (3.76) < 0.001
Pre-operative urea 6.98 (3.29) 7.34 (4.03) 8.25 7.51 (3.12) 8.52 (6.11) < 0.001
Urea 12–24 h after surgery 7.24 (5.47) 8.11 (16.73) 8.55 8.19 (9.95) 9.37 (8.95) < 0.001
Urea at day 2 after surgery 10.13 (23.15) 10.51 (25.40) 11.89 14.51 (35.13) 12.76 (24.00) < 0.001
Urea at day 4 after surgery 8.49 (24.49) 9.32 (29.78) 10.74 14.14 (49.26) 11.35 (16.44) < 0.001
Maximum CPB flow 4.63 (1.47) 4.12 (1.97) 3.96 (2.05) 4.02 (2.05) 4.14 (2.01) < 0.001
Duration of perfusion 100.07 (38.64) 125.29 (48.12) 169.76 (73.36) 168.07 (50.43) 214.06 (77.13) 0.000
Aortic cross-clamp time 58.94 (25.42) 83.36 (32.28) 109.93 (53.19) 110.25 (31.48) 137.22 (52.95) 0.080
HR at start surgery 62.22 (12.90) 67.14 (14.00) 70.80 (17.52) 62.55 (13.90) 66.17 (16.06) 0.000
HR during perfusion 66.39 (57.83) 61.24 (55.15) 61.80 (53.20) 60.09 (57.94) 63.58 (61.49) < 0.001
SBP at start surgery (mmHg) 113.54 (34.62) 108.81 (31.98) 102.25 (31.32) 109.36 (33.49) 105.28 (29.93) 0.002
SBP during perfusion 61.76 (21.39) 63.37 (22.60) 63.17 (20.39) 63.96 (20.10) 62.83 (22.03) < 0.001
DBP at start surgery (mmHg) 64.81 (31.81) 61.87 (29.18) 60.45 (27.90) 60.51 (29.65) 58.87 (22.32) 0.012
DBP during perfusion 56.53 (18.09) 58.52 (18.88) 57.58 (17.00) 59.16 (17.66) 57.39 (17.37) < 0.001
CVP at start surgery (mmHg) 12.58 (30.79) 11.96 (28.43) 13.88 (30.11) 12.89 (32.66) 12.32 (24.81) < 0.001
CVP during perfusion 6.62 (8.31) 5.03 (9.45) 4.78 (15.07) 5.65 (5.60) 4.44 (7.75) 0.653
PaCO2 at start surgery (kPa) 5.02 (0.63) 5.08 (0.70) 5.03 (0.69) 5.07 (0.64) 5.01 (0.72) < 0.001
PaCO2 during perfusion 5.04 (0.54) 5.17 (0.57) 5.18 (0.62) 5.09 (0.51) 5.13 (0.57) 0.010
PaCO2 at end surgery 4.84 (0.59) 4.87 (0.63) 4.99 (0.74) 4.89 (0.62) 5.04 (0.72) < 0.001
PaO2 at start surgery (kPa) 21.49 (14.95) 22.11 (14.43) 22.03 (14.74) 20.65 (12.85) 19.81 (12.93) < 0.001
PaO2 during perfusion 26.70 (10.88) 25.59 (10.36) 25.88 (9.82) 25.87 (9.37) 26.82 (10.52) 0.018
PaO2 at end surgery 17.79 (11.58) 22.27 (13.04) 21.93 (12.82) 21.30 (12.62) 20.37 (11.37) 0.001
SaO2 at start surgery (%) 0.98 (0.03) 0.98 (0.03) 0.98 (0.05) 0.98 (0.03) 0.98 (0.02) < 0.001
SaO2 during perfusion 0.99 (0.03) 0.99 (0.05) 0.99 (0.05) 0.99 (0.03) 0.99 (0.06) 0.206
SaO2 end surgery 0.98 (0.03) 0.99 (0.04) 0.98 (0.04) 0.98 (0.04) 0.98 (0.02) 0.152
ICU stay (hours) 52.44 (163.21) 47.51 (138.81) 88.79 (216.86) 88.72 (260.41) 141.13 (267.53) < 0.001
ESR within 24 h before 
surgery (mm/h) 20.61 (19.57) 18.63 (19.96) 20.21 (19.40) 22.23 (20.25) 23.01 (21.03) < 0.001
Pre-operative ESR 20.85 (19.77) 17.98 (19.27) 19.22 (19.06) 21.22 (19.82) 23.15 (19.74) < 0.001
LDH within 24 h before 
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CABG Aortic valve Mitral valve Aortic + coronary Mitral + coronary
P valueN = 4514 N = 1663 N = 884 N = 813 N = 367
Pre-operative LDH 228.65 (76.10) 250.27 (142.33) 273.05 (428.61) 236.90 (74.54) 230.82 (74.38) < 0.001
LDH 12- 24 h after surgery 338.15 (273.89) 396.80 (179.67) 480.19 (484.17) 456.26 (497.74) 510.39 (662.83) < 0.001
LDH at day 2 after surgery 338.30 (233.89) 388.29 (252.01) 461.39 (444.76) 446.04 (312.62) 474.68 (264.37) < 0.001
LDH at day 4 after surgery 327.78 (882.49) 382.96 (703.42) 413.65 (329.29) 424.52 (461.76) 439.23 (340.88) < 0.001
Maximum post-operative 
LDH 421.61 (896.25) 461.39 (377.02) 568.32 (731.73) 558.72 (709.25) 592.21 (543.21) < 0.001
Blood glucose 0–6 h after 
surgery (mmol/L) 9.41 (2.46) 8.41 (2.48) 8.47 (2.84) 8.48 (2.73) 9.02 (2.70) < 0.001
Blood glucose 6–12 h after 
surgery 10.22 (2.43) 9.56 (2.00) 9.49 (2.27) 9.67 (2.15) 9.57 (2.26) < 0.001
Blood glucose 12–24 h after 
surgery 9.14 (2.48) 8.39 (2.07) 8.17 (2.21) 8.27 (2.13) 8.12 (2.08) < 0.001
Maximum post-operative 
glucose 11.19 (4.37) 10.38 (3.84) 10.48 (2.58) 10.53 (2.24) 10.82 (2.69) < 0.001
Hb within 24 h before sur-
gery (mmol/L) 8.47 (1.09) 8.45 (1.06) 8.27 (1.20) 8.35 (1.00) 8.30 (1.11) < 0.001
Pre-operative Hb 8.19 (1.36) 8.24 (1.78) 8.10 (1.65) 8.26 (2.44) 8.34 (2.90) < 0.001
Hb 0–6 h after surgery 5.64 (0.73) 5.69 (0.76) 5.78 (0.82) 5.52 (0.76) 5.57 (0.84) 0.135
Hb 6–12 h after surgery 6.02 (0.85) 6.35 (1.16) 6.22 (0.93) 5.92 (0.84) 5.80 (0.89) < 0.001
Hb 12–24 h after surgery 6.18 (0.78) 6.40 (0.85) 6.25 (0.88) 6.01 (0.77) 5.92 (0.80) < 0.001
Hb at day 2 after surgery 6.31 (0.78) 6.26 (0.81) 6.09 (0.86) 6.01 (0.75) 5.92 (0.76) < 0.001
Hb at day 4 after surgery 6.52 (0.87) 6.40 (1.33) 6.22 (0.89) 6.07 (0.81) 5.97 (0.82) < 0.001
Minimum post-operative Hb 5.31 (0.69) 5.41 (0.73) 5.29 (0.77) 5.11 (0.65) 5.01 (0.70) < 0.001
Leukocytes within 24 h 
before surgery (× 109/L) 7.84 (2.73) 7.44 (2.70) 7.62 (3.32) 7.77 (3.22) 7.74 (2.18) < 0.001
Pre-operative leukocytes 8.01 (2.96) 7.53 (2.63) 7.79 (3.12) 7.88 (2.99) 7.88 (2.46) < 0.001
Leukocytes 12–24 h after 
surgery 13.95 (4.41) 13.71 (4.36) 13.79 (4.17) 13.57 (4.93) 13.49 (4.22) < 0.001
Leukocytes at day 2 after 
surgery 17.08 (4.82) 15.79 (4.81) 15.99 (5.12) 16.14 (4.74) 16.49 (4.85) 0.051
Leukocytes at day 4 after 
surgery 11.52 (4.15) 10.00 (4.06) 10.93 (9.74) 10.99 (3.94) 11.96 (4.78) < 0.001
Thrombocytes within 24 h 
before surgery (× 109/L) 246.55 (73.47) 231.91 (67.44) 235.83 (72.42) 234.86 (69.37) 239.06 (72.70) < 0.001
Pre-operative thrombocytes 238.69 (78.71) 224.72 (71.67) 230.34 (75.95) 230.41 (73.07) 233.71 (76.22) < 0.001
Thrombocytes 0–6 h after 
surgery 152.85 (52.79) 131.80 (44.10) 132.02 (44.78) 129.11 (46.63) 131.97 (48.12) < 0.001
Thrombocytes 6–12 h after 
surgery 171.17 (58.06) 149.14 (49.54) 141.39 (48.69) 136.37 (47.14) 140.20 (54.93) < 0.001
Thrombocytes 12–24 h after 
surgery 174.48 (57.73) 151.22 (50.74) 141.85 (47.48) 136.92 (46.77) 138.73 (53.92) < 0.001
ALAT within 24 h before 
surgery (U/L) 40.56 (35.46) 28.54 (26.10) 31.48 (29.11) 30.31 (28.08) 31.99 (26.70) < 0.001
Pre-operative ALAT 40.80 (35.28) 28.86 (27.93) 33.58 (57.80) 30.40 (26.64) 33.25 (34.18) < 0.001
ALAT 12–24 h after surgery 37.49 (79.01) 29.24 (37.05) 43.72 (160.67) 35.59 (135.12) 46.14 (198.66) < 0.001
ALAT at day 2 after surgery 37.57 (146.05) 31.20 (88.67) 44.26 (123.93) 40.56 (168.31) 40.43 (105.37) 0.002
ASAT within 24 h before 
surgery (U/L) 32.72 (20.36) 29.50 (20.19) 31.83 (24.10) 28.95 (15.01) 31.08 (28.86) 0.169
Pre-operative ASAT 33.18 (24.15) 30.11 (24.14) 37.82 (166.12) 29.45 (15.34) 30.90 (18.47) < 0.001
ASAT 12–24 h after surgery 59.82 (108.39) 71.96 (83.88) 112.66 (241.82) 98.08 (206.81) 121.96 (283.96) < 0.001
ASAT at day 2 after surgery 53.36 (171.29) 58.70 (113.12) 92.51 (194.80) 89.26 (347.04) 90.90 (115.64) 0.011
ASAT at day 4 after surgery 55.12 (422.01) 54.44 (197.38) 68.11 (217.54) 72.37 (435.80) 71.26 (248.91) < 0.001
Neutrophils 12–24 h after 
surgery (× 109/L) 12.29 (3.86) 12.07 (3.86) 12.07 (3.80) 11.86 (3.96) 11.79 (3.82) 0.584
Monocytes 12–24 h after 
surgery (× 109/L) 1.10 (1.73) 1.32 (2.07) 1.51 (2.25) 1.42 (2.33) 1.34 (2.20) 0.004
Lymphocytes 12–24 h after 
surgery (× 109/L) 1.05 (2.05) 1.12 (1.86) 1.35 (2.60) 1.15 (1.93) 1.34 (3.11) < 0.001
5-year mortality: 0.001
Alive 3890 (86.18%) 1382 (83.10%) 710 (80.32%) 642 (78.97%) 261 (71.12%) < 0.001
Deceased 624 (13.82%) 281 (16.90%) 174 (19.68%) 171 (21.03%) 106 (28.88%)
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to baseline. Likewise, mortality risk gradually increased between 60 and 80 years of age. Figure 4 illustrates the 
combined effect of serum urea day 4 and age on mortality risk.
Discussion
This study shows that ensemble ML analysis achieves a high accuracy in predicting 5-year mortality in a cohort 
of 8241 patients with CABG and/or valve operations. Moreover, variable importance analysis revealed early 
postoperative urea as a novel and strong predictor of mortality in all types of cardiac operations. Furthermore, 
methodologically, a more targeted approach of training the algorithms on sub-groups instead of the full cohort 
did not significantly improve mortality prediction.
We demonstrated that using an ensemble algorithm with a combination of pre-operative, intra-operative, 
and first week post-operative data, achieves high accuracy in predicting 5-year mortality after different types of 
cardiac operations. These findings extend a previous study where we demonstrated the superiority of individual 
ML models compared to classical multivariable analysis in identifying patients at increased risk of long-term 
mortality after  CABG7. Here, we reaffirm these findings using ensemble ML and data from different types of 
cardiac operations. Using peri-operative data, we achieved similar accuracy to a recently developed ML-based 
risk algorithm for prediction of 1- to 24-month mortality following major  surgery15. Compared to other models 
that predict mortality specifically after cardiac surgery, the ensemble achieved superior  performance8.
The application of algorithms such as the one we developed to pre-operative data would possibly predict 
patients at the highest risk of long-term complications prior to surgery. Expectedly, analysis of pre-operative 
data in the XGBoost model decreased performance significantly, which could be partly due to the limited set 
of pre-operative data available in our cohort, or to the lower frequency of the outcome (long-term mortality 
CABG Aortic valve Mitral valve Aortic + coronary Mitral + coronary
P valueN = 4514 N = 1663 N = 884 N = 813 N = 367
AKI staging < 0.001
No AKI 3063 (67.86%) 1142 (68.67%) 584 (66.06%) 462 (56.83%) 199 (54.22%) < 0.001#
Mild subclinical AKI 841 (18.63%) 268 (16.12%) 133 (15.05%) 145 (17.84%) 62 (16.89%)
Moderate subclinical AKI 142 (3.15%) 51 (3.07%) 26 (2.94%) 37 (4.55%) 14 (3.81%)
AKI 1–3 468 (10.37%) 202 (12.15%) 141 (15.95%) 169 (20.79%) 92 (25.07%)
AKI 1 441 (9.77%) 191 (11.49%) 126 (14.25%) 157 (19.31%) 90 (24.52%)
AKI 2 9 (0.20%) 6 (0.36%) 11 (1.24%) 6 (0.74%) 2 (0.54%)
AKI 3 18 (0.40%) 5 (0.30%) 4 (0.45%) 6 (0.74%) 0 (0%)
Table 1.  Descriptives table per operation type. All values presented as mean (95% CI), and categorical variable 
with the percentage in parentheses. BMI body mass index, eCCR estimated creatinine clearance, CPB cardio-
pulmonary bypass, HR heart rate, SBP systolic blood pressure, DBP diastolic blood pressure, CVP central 
venous pressure, PaCO2 arterial  CO2 pressure, PaO2 arterial oxygen pressure, SaO2 oxygen saturation, ICU 
intensive care unit, ESR erythrocyte sedimentation rate, LDH lactate dehydrogenase, Hb hemoglobin, ALAT 
alanine aminotransferase, ASAT aspartate aminotransferase, AKI acute kidney injury. # Significance level 
presented is for AKI 1–3 combined, given that there are no patients in the mitral + coronary group with AKI 3.
Figure 1.  Plot of the receiver operating characteristic (ROC) curves and the respective areas under curve 
(AUCs) for the weighted Super Learner 1 for each of the 5 types of operation and for the whole cohort. Plot 
of the receiver operating characteristic (ROC) curves and the respective areas under curve (AUCs) for the 
weighted Super Learner and the generalized linear model (GLM) for the whole cohort. SL super learner, CABG 
coronary artery bypass grafting.
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Figure 2.  Specificity (blue) and sensitivity (red) values across all possible thresholds for all operations 
combined. The default 0.50 threshold is marked in grey, the threshold based on the maximized Youden index in 
black, and the threshold representing a 50% increase in mortality risk in green.
Figure 3.  Top ten predictor variables for all types of operations combined. Variable coefficients indicate 
how much each parameter contributes to the outcome. eCCR estimated creatinine clearance, LDH lactate 
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as opposed to short-term post-operative complications). Yet, it should be noted that the model’s performance 
using our restricted set of pre-operative data has comparable predictive power as currently used clinical  scores8.
Methodologically, our study contributed to the discussion on the need of conducting predictive studies on 
operation-specific cohorts. Results from previous studies suggest that algorithms trained on pooled data from 
patients undergoing different types of surgeries were accurate in predicting outcomes for all these types of opera-
tions. In keeping, our findings show that both the model trained with the full cohort, and the models trained 
with the individual cardiac operation subgroups showed a good performance in predicting long-term mortal-
ity after aortic and mitral valve operations. This finding further questions the need to conduct ML analyses on 
operation-specific cohorts. Specifically, including full cohorts may lead to better model performance analyses 
due to the greater amount of data.
Additionally, by providing risk predictions at individual level, ML algorithms allow for the adjustment of 
the sensitivity and specificity of each model for different clinical  settings15. Balancing sensitivity and specificity 
in the context of mortality risk predictions can be challenging. Lowering the prediction threshold may lead to 
excessive over-diagnosing and increase in healthcare costs. However, especially in populations with relatively 
low mortality rates such as cardiac surgery patients, a too high threshold would miss too many “non-survivors”. 
Here, we demonstrated that using a 50% increase in absolute risk of mortality as cut-off provides a favorable 
trade-off between false positives and true negatives, as previously shown in similar large studies predicting 
postoperative mortality and mortality in intensive care  patients15,16. Validation of this approach merits further 
investigation, and may facilitate the translation of an algorithm’s good predictive performance into a clinically 
useful patient risk stratification  tool17.
Variable importance analysis identified postoperative urea as the strongest predictor of 5-year mortality. This 
is consistent with our previous findings in a CABG-only  population7. Yet, literature on the possible role of urea 
as a mortality predictor in cardiac operations is  scarce7. Preoperative urea values above 10 mmol/L have been 
found to be associated with increased 30-day mortality risk after CABG and with increased risk of stroke in the 
10 days after cardiac  operations18,19. It should also be noted that, in heart failure patients, increased urea levels 
have been associated with derangements in cardiac output and renal  perfusion20,21. These are, in turn, strongly 
related to patients’ overall performance status and prognosis, with both urea and the urea/creatinine ratio being 
known prognostic  predictors22. In the context of this study, increased urea may originate from excess production 
and/or impaired excretion, yet mechanistic insight remains elusive. Possibly, urea production may be increased 
by mitochondrial dysfunction, caused by ischemia/reperfusion and increased systemic inflammatory response 
after cardiopulmonary bypass and surgical  trauma23. Mitochondrial dysfunction may be amplified through excess 
Table 2.  Percentage of correctly classified cases in survivors and non-survivors per operation type for SL1 
predictions using the default and 50% increase in risk thresholds.
Predictions matching actual patient 
outcome (%)
Survivors (%) Non-survivors (%)
Aortic valve
With default threshold 98.8 18.1
With 50% increased risk threshold 90.5 53.0
Difference − 8.3 + 34.9
Mitral valve
With default threshold 96.8 34.5
With 50% increased risk threshold 89.7 59.8
Difference − 7.1 + 25.3
CABG
With default threshold 99.2 10.4
With 50% increased risk threshold 88.9 47.9
Difference − 9.3 + 37.5
Aortic + CABG
With default threshold 97.0 19.9
With 50% increased risk threshold 88.8 43.3
Difference − 8.2 + 23.4
Mitral + CABG
With default threshold 96.9 28.3
With 50% increased risk threshold 95.4 34.9
Difference − 1.5 + 6.6
All operations combined
With default threshold 98.6 17.7
With 50% increased risk threshold 89.4 51.6
Difference − 9.2 + 33.9
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reactive oxygen species (ROS) following accumulation of succinate during  ischemia24,25. Additionally, recent 
evidence indicates that high urea levels generate  ROS26. Furthermore, renal excretion of urea may decrease in 
response to kidney injury. Thus, urea likely reflects the compound pathological state of different organ systems, 
rather than just kidney function.
Lastly, this study also has some limitations to consider. Being a single center study, our findings need confir-
mation by external validation. Further, our analysis is limited to the variables in the CAROLA database. Detailed 
co-morbidity information, for instance, could help further improve model performance, especially for the CABG 
sub-group. Additionally, variable importance analysis as such does not provide directionality and assumptions 
about effect size between the variables and the outcome cannot be made directly. Finally, the current ensemble 
ML is not suited to use high-frequency, high-volume data, such as continuous intraoperative measurements of 
blood pressure, heart rate, oxygen saturation or temperature. Therefore, a study including algorithms suitable 
for such analysis, such as recurrent neural networks, is a logical follow-up.
In conclusion, ML analysis of 88 routinely collected peri-operative data achieved a high accuracy in predict-
ing 5-year mortality after different cardiac operations in this large study of 8241 patients. A targeted approach of 
training the algorithms on sub-groups instead of the full cohort did not improve model performance. Moreover, 
variable importance analysis showed early postoperative urea as a novel and strong predictor of mortality in all 
types of cardiac operations. Similar studies enabling the identification of modifiable risk factors and providing 
individual patient predictions may form a first step towards facilitating personalized clinical interventions to 
improve patient care.
Methods
The electronic Cardiothoracic Anesthesiology Registry (CAROLA) comprises extensive prospective data of all 
adult patients who underwent first-time valve operation, CABG, or a combination of both between 1997 and 
2017 in the University Medical Centre Groningen (UMCG), the Netherlands. The total number of patients is 
11,286. This database study was approved by the Medical Ethical Committee of the UMCG, and the requirement 
to obtain informed consent was waived (waiver: METC#2010/118). All analyses were performed in accordance 
with relevant guidelines and regulations.
Patient population and outcome. Only patients who underwent valve operation, either solitary or com-
bined with coronary artery bypass grafting (CABG), or solitary CABG, with cardiopulmonary bypass (CPB) 
were included (n = 8241). There were 1663 patients in the combined aortic and coronary group, 367 in the com-
bined mitral and coronary group, 884 in the solitary mitral group, 813 in the solitary aortic group, and 4514 in 
the CABG-only group. Mortality data were obtained in November 2017 from the Dutch Municipal Personal 
Records Database comprising actual and reliable data of all citizens within the Netherlands.
Data selection and pre‑processing. The dataset includes patient characteristics, peri-operative hemody-
namic, CPB, respiratory and organ function data and blood values collected at different time points indicated in 
Fig. 5. Because for some patients referred from other hospitals the stay in our center was limited to the immedi-
ate peri-operative phase, a variable pattern of missing data was observed. Multivariate imputation by chained 
equations was performed on the set of variables with at least 50% non-missing  data27. The final dataset without 
missing data consisted of 88 predictor variables and 5-year mortality as the outcome variable (Table 1). Baseline 
serum creatinine measurements was defined as the closest to the start of operation. Patients were classified for 
post-operative AKI 0–3 within the 7 days after operation according to the AKIN  classification3.
Statistical analysis. The Super Learner, selected candidate algorithms, and hyper‑parameter tuning. The 
Super Learner algorithm is a generalization of the stacking algorithms developed by  Breiman28, which combines 
a set of candidate algorithms to make k-fold-cross-validated  predictions9,29. In this process, the dataset is divided 
into k mutually exclusive and exhaustive subsets, with one set serving as a validation set, while the others are 
Figure 4.  Partial dependence plots of urea at postoperative day 4 and age. Partial dependence plots of urea at 
postoperative day 4 against age. The vertical bar represents predicted risk (blue to red, low to high).
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used for training each candidate  algorithm14. This means that each patient is used only once in the validation 
set, and included in the training set for all other rounds. For each candidate learner, k risks are calculated and 
averaged into a “cross-validated risk”. Subsequently, the learners with the minimal risk are selected, applied to 
the entire dataset and included in the new weighted estimator (the SL), that attributes a relative coefficient to 
each of the learners. Those which reduce the calculated risk the most, will contribute to the final weighted pre-
diction. Moreover, the SL presents individual patient predicted probabilities for 5-year mortality per ensemble. 
Five candidate algorithms were included in the SL: support Bayesian additive regression trees (BART), extremely 
randomized trees, elastic net, support vector machine, and extreme gradient boosted machine (XGBoost). De-
tails of these five algorithms can be found in the “Supplementary material”. Since the performance of an algo-
rithm varies greatly depending on its hyper-parameters and can be substantially improved by tuning, multiple 
hyper-parameter combinations were generated for each candidate algorithm. Details of each of these algorithms 
including the hyper-parameters, the tuning process, and final values are described in the “Supplementary ma-
terial”. A 10-fold cross-validated generalized linear regression model (GLM) was trained on data from the full 
cohort for use as baseline comparison of the SL’s performance. Lastly, to test the performance of a model using 
only pre-operative data in predicting post-operative outcomes, a 10-fold cross-validated XGBoost model was 
trained on data from the full cohort.
Model training. Two distinct training procedures for the SL were carried out (Fig. 6). First, one of the ensembles 
(SL1) was trained using the full cohort of 8241 patients. Secondly, the cohort was split into five different groups 
according to operation type, with one ensemble trained on data from each group (SL2–SL6). All six ensembles 
included the same candidate algorithms, and the same hyper-parameter configurations. Performance of two dif-
ferent approaches were assessed by comparison of the 10-fold cross-validated area under the receiver operated 
characteristic curve (AUROC), with a 95% confidence interval, for each of the weighted SL’s. Differences in the 
performance between SL’s and between SL1 and the GLM were assessed with DeLong’s nonparametric test for 
the difference in areas under the  curve30.
Calibration, sensitivity analysis and adjusted risk thresholds based on predicted probability of mortality. Calibra-
tion plots and calibration indices (ECI)31 for all models are provided in the “Supplementary material”. Model 
performance metrics described above were obtained in a 2-step procedure: first using a default threshold to 
maximize the AUROC, and then using adjusted thresholds to optimize sensitivity and specificity. This process 
of tuning the operating points of the ROC using different risk thresholds depending on the requirements of a 
specific clinical setting has been previously shown to optimize model sensitivity and specificity for mortality 
 prediction15. In the first step, a default threshold of 0.50 was used, where patients are classified as “non-survivors” 
if the predicted probability of mortality is greater than 50%. This is the standard threshold used to maximize 
algorithm performance during training. After this, a second and third risk thresholds were defined. The second 
one was calculated based on the maximized Youden index, which provides a balance between sensitivity and 
 specificity15. The third one was based on the actual long-term mortality rate of each of the surgical sub-groups, 
and corresponds to a 50% increase in the absolute risk of mortality. We opted for this value as it represents a 
clinically relevant increase that could justify intervention. The confusion matrix, sensitivity, and specificity for 
each of the thresholds are reported in the “Supplementary material”.
Figure 5.  Timeline of clinical measurements before, during, and after cardiac operation, in the intensive 
care unit (day 1 after operation), day 1 in the ward (day 2 after operation), and day 3 in the ward (day 4 after 
operation). Patient characteristics are not included here, but described in detail in Table 1. Dur CA duration of 
cardiac arrest, Dur clamp duration of aortic cross-clamp, Hb hemoglobin, ASAT aspartate aminotransferase, 
ALAT alanine aminotransferase, Thromb thrombocytes, ESR erythrocyte sedimentation rate, LDH lactate 
dehydrogenase, CVP central venous pressure, PaCO2 arterial carbon dioxide partial pressure, SaO2 oxygen 
saturation, PaO2 arterial oxygen partial pressure, SBP systolic blood pressure, DBP diastolic blood pressure.
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Variable importance analysis. Variable importance measures aim at estimating the contribution of predictor 
variables to changes in the  outcome32. The greater the association between each feature and the outcome, the 
greater the decrease in accuracy upon its removal, and the higher its reported  importance32. We determined the 
variable importance of all routinely measured peri-operative clinical parameters in our cohort by training the 
best performing individual algorithm included in the ensemble—the XGBoost model—using the same hyper-
parameter configurations as in the SL. The coefficients for the top ten features for each operation type, as well as 
for all operations combined, are presented.
All analyses were performed using R version 3.6.2 (The R Foundation for Statistical Computing; Vienna, 
Austria) for Ubuntu 16.04 LTS. Data are expressed as mean (95% confidence interval), and categorical as per-
centages. A P value < 0.05 was accepted as a statistically significant difference.
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